Citius Oncology Inc Is A Buy Small Cap Stock: Analysts

Citius Oncology Inc (NASDAQ:CTOR) has a beta value of 0.30 and has seen 39.94 million shares traded in the recent trading session. The company, currently valued at $60.12M, closed the recent trade at $0.84 per share which meant it gained $0.17 on the day or 26.36% during that session. The CTOR stock price is -5733.33% off its 52-week high price of $49.00 and 34.52% above the 52-week low of $0.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.29 million shares traded. The 3-month trading volume is 128.15K shares.

Citius Oncology Inc (NASDAQ:CTOR) trade information

Sporting 26.36% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CTOR stock price touched $0.84 or saw a rise of 27.59%. Year-to-date, Citius Oncology Inc shares have moved -26.93%, while the 5-day performance has seen it change 18.35%. Over the past 30 days, the shares of Citius Oncology Inc (NASDAQ:CTOR) have changed -29.39%. Short interest in the company has seen 27881.0 shares shorted with days to cover at 0.54.

Citius Oncology Inc (CTOR) estimates and forecasts

The company’s shares have lost -41.24% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.

1 analysts offering their estimates for the company have set an average revenue estimate of 5.74M for the current quarter. 1 have an estimated revenue figure of 8.6M for the next ending quarter.

CTOR Dividends

Citius Oncology Inc is expected to release its next earnings report on 2025-Feb-13 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Citius Oncology Inc (NASDAQ:CTOR)’s Major holders

Insiders own 95.08% of the company shares, while shares held by institutions stand at 0.89% with a share float percentage of 18.10%. Investors are also buoyed by the number of investors in a company, with Citius Oncology Inc having a total of 14.0 institutions that hold shares in the company.